Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1486-1496
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1486
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1486
Cut-off value | Training cohort | Validation cohort | |||||||||
AUC (95%CI) | SEN (%) | SPE (%) | PPV (%) | NPV (%) | AUC (95%CI) | SEN (%) | SPE (%) | PPV (%) | NPV (%) | ||
HCC | 0.22 | 0.960 (0.950-0.971) | 94.40 | 95.35 | 87.25 | 98.10 | 0.966 (0.945-0.986) | 90.00 | 94.20 | 89.87 | 95.47 |
Early HCC | 0.946 (0.901-0.991) | 85.93 | 93.62 | 61.11 | 98.28 | 0.947 (0.901-0.994) | 89.10 | 98.49 | 94.23 | 97.02 |
- Citation: Liu ZJ, Xu Y, Wang WX, Guo B, Zhang GY, Luo GC, Wang Q. Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes. World J Gastrointest Oncol 2023; 15(8): 1486-1496
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1486.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1486